Tourmaline Bio Stock Revenue
| TRMLDelisted Stock | 47.98 0.00 0.00% |
Fundamental analysis of Tourmaline Bio allows traders to better anticipate movements in Tourmaline Bio's stock price by examining its financial health and performance throughout various phases of its business cycle.
Tourmaline |
Tourmaline Bio Company Revenue Analysis
Tourmaline Bio's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Tourmaline Bio reported 0.0 of revenue. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The revenue for all United States stocks is 100.0% higher than that of the company.
Tourmaline Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tourmaline Bio's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tourmaline Bio could also be used in its relative valuation, which is a method of valuing Tourmaline Bio by comparing valuation metrics of similar companies.Tourmaline Bio is currently under evaluation in revenue category among its peers.
Tourmaline Fundamentals
| Return On Equity | -0.3 | |||
| Return On Asset | -0.21 | |||
| Current Valuation | 993.63 M | |||
| Shares Outstanding | 25.69 M | |||
| Shares Owned By Insiders | 14.62 % | |||
| Shares Owned By Institutions | 89.12 % | |||
| Number Of Shares Shorted | 808.96 K | |||
| Price To Book | 4.75 X | |||
| EBITDA | (89.73 M) | |||
| Net Income | (73.21 M) | |||
| Total Debt | 244 K | |||
| Book Value Per Share | 10.09 X | |||
| Cash Flow From Operations | (77.26 M) | |||
| Short Ratio | 1.12 X | |||
| Earnings Per Share | (3.44) X | |||
| Target Price | 48.0 | |||
| Number Of Employees | 76 | |||
| Beta | 1.58 | |||
| Market Capitalization | 1.23 B | |||
| Total Asset | 309 M | |||
| Retained Earnings | (135.26 M) | |||
| Working Capital | 259.93 M | |||
| Net Asset | 309 M |
About Tourmaline Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tourmaline Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tourmaline Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tourmaline Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in Tourmaline Stock
If you are still planning to invest in Tourmaline Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tourmaline Bio's history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| CEOs Directory Screen CEOs from public companies around the world |